Paloma Health
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Paloma Health - overview
Established
2019
Location
New York, NY, US
Primary Industry
Healthcare Specialists
About
Based in New York, US, and founded in 2019, Butterfly Technologies Inc. , doing business as Paloma Health, operates as a healthcare technology firm that sells thyroid blood test kits. The company was founded by its CEO, Guillaume Cohen-Skalli, and Marina Tarasova. Paloma Health offers a virtual care platform, a remote thyroid care platform that links patients with healthcare professionals and enables patients to receive thyroid care that can be accessed from their residences.
The company's doctors consult with patients online, request lab work, write prescriptions when necessary, and even market kits for at-home lab testing. In addition, the company offers a mobile application for both Android and iOS users. The company generates revenue by offering its services on a subscription-based pricing plan. The plans include self-pay (USD 192/month), at-home thyroid kits (USD 75/month), online doctor visits, and vitamin supplements (USD 27/month).
Current Investors
FJ Labs, Aera
Primary Industry
Healthcare Specialists
Sub Industries
Mental Health Services
Website
www.palomahealth.com
Verticals
HealthTech, Mobile Apps
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.